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Abstract
In evidence-based medicine (EBM) hierarchy, randomized controlled trials (RCTs) are ranked higher than cohort studies.
However, cohort intervention studies are frequently, and RCTs rarely, used to investigate long-term psychotherapy (LTP).
The authors compare the two methods and provide critical discussion of their acceptability, feasibility, and decisive power in
LTP. The only essential and unchangeable difference between RCTs and cohort studies is that the former always include
randomized control groups and the latter never do, giving RCTs a head start on internal validity that cohort studies cannot
match. However, randomization nearly always has dramatic consequences for LTP research: The control conditions that are
most informative (no treatment, wait list, placebo) are so unacceptable for the patients that decisive RCTs are, in most
cases, unfeasible, but more feasible RCTs are less decisive. In contrast, the decisive power of cohort studies is determined by
their methodological quality and knowledge of the natural course of the investigated disorders. Cohort studies are as capable
as RCTs of meeting all quality criteria for intervention research, except for randomization. The knowledge of the natural
course of the disorders suitable for LTP treatment is limited but not nonexistent. In most cases of LTP research, decisive
RCTs present insurmountable, method-inherent feasibility problems and represent not the highest but rather an irrelevant
level of evidence. The authors conclude that cohort studies provide the best available evidence.
Psychotherapy is not an applied science but rather a
scientifically based art and skill. The general criteria
of science, among others, apply to the field. The
American Psychological Association (Chambless &
Hollon, 1998; Task Force on Promotion and Dis-
semination of Psychological Procedures, 1995) has
defined quality criteria to assess whether or not the
effectiveness of a psychotherapeutic method has
been sufficiently substantiated empirically to deserve
the qualification. Empirically supported psychologi-
cal therapy (ESPT; Kendall, 1998) meets the
standards of evidence-based medicine (EBM): ‘‘the
conscientious, explicit and judicious use of current
best evidence in making decisions about the care of
individual patients. The practice of evidence-based
medicine requires the integration of individual,
clinical expertise with the best available, external,
clinical evidence from systematic research and our
patients’ unique values and circumstances’’ (Centre
for Evidence-Based Medicine, n.d.).
Researchers in the field of treatment effectiveness
(outcome research, not process research) agree that
empirical evidence can and must be ordered in a
hierarchical system. A widely accepted hierarchy
(Centre for Evidence-Based Medicine, 2001) is as
follows:
1a. A systematic review of RCTs with consistent
results
1b. One high-quality RCT
1c. One all-or-none study
2a. A systematic review of cohort studies or of
patientcontrol studies with consistent results
2b. One cohort- or patient-control study or one
lower quality RCT
2c. Outcome research
3a. A systematic review of casecontrol studies
3b. A casecontrol study
4. Case series or a lower quality cohort study
5. Expert’s opinions or generally accepted thera-
peutic methods
RCTs, or their systematic reviews and meta-
analyses, occupy first place in this hierarchy and
cohort studies second. A cohort is a well-defined
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group of people who are monitored over a specific
period of time to observe whether a certain outcome
occurs. The relation between a determinant (in our
case long-term psychotherapy [LTP]) and outcome
(the effect) is scrutinized. If the determinant is an
intervention, this design is also called a quasi-
experimental study: ‘‘experiments that lack random
assignment. . .but that otherwise have similar pur-
poses and structural attributes to randomized ex-
periments’’ (Shadish, Cook, & Campbell, 2002).
Quasi-experimental studies may or may not include
a comparison group. In this study, we apply the term
cohort study because we believe it is most frequently
used in EBM literature.
Psychotherapy has been extensively investigated
with RCTs (see, e.g., the systematic reviews of Crits-
Christoph, 1992; Leichsenring & Leibing, 2003;
Leichsenring, Rabung, & Leibing, 2004; Perry,
Banon, & Ianni, 1999). Together, these four reviews
refer to 28 different RCTs, 27 of them short-term
psychotherapy (STP) and only 1 of them LTP.
RCTs have frequently studied short-term therapies
and rarely long-term therapies in general and espe-
cially in psychotherapy. This state of affairs has led
to the common opinion that LTP is not an ESPT. Its
effectiveness would not have been researched scien-
tifically, let alone convincingly demonstrated. This
conclusion is based on two premises: (a) that
conclusive RCTs are feasible in LTP research and
(b) that RCTs are superior to cohort studies in all
important methodological aspects. We discuss these
views and assess their validity. We apply an arbitrary
distinction between STP and LTP: The latter




RCTs derive their name from their most important
characteristic: the randomization of patients. This
study design is also called the confirmatory-deduc-
tive methodology and is applied in efficacy research.
RCTs strive for a maximum internal validity, so that
it can be assumed, beyond reasonable doubt, that
differences found between treatment and control
groups (the dependent variable) are explained by the
therapeutic intervention (the independent variable).
Within reasonable limits, this method ensures like no
other that chance is the only alternative explanation
for the differences found between the studied
groups. Factors possibly (co)determining results
(confounders) are neutralized as much as possible.
To this end, the groups have to be, apart from the
intervention concerned, comparable to each other
(e.g., regarding demographical and clinical charac-
teristics). The tool to achieve this is random assign-
ment. This means patients are allocated by chance to
either the experimental treatment or the control
condition. As Kunz and Oxman (1998) state, ‘‘It is a
paradox that unpredictability is introduced into the
design of clinical trials by using random allocation to
protect against the unpredictability of the extent of
bias in the results of non-randomized clinical trials.’’
The advantages of randomization are obvious and
justify the high ranking of RCTs within the hierarchy
of empirical evidence. However, this does not
diminish the fact that, especially over the past
decade, RCTs have been severely criticized as well,
not only in the field of psychotherapy and regardless
of treatment length (Crits-Christoph, 1997; Healy,
2001; Hollon, 1996; Howard, Moras, Brill, Marti-
novich, & Lutz, 1996; Kaptchuck, 2001; Leichsenr-
ing, 2004; Marks, 1997; Seligman, 1995). The
criticism focuses primarily on the external validity
of RCTs (i.e., on the generalizability of their results
to daily practice). Many patients refuse participa-
tion, are excluded, or drop out. The manuals and
protocols applied, the many assessments, and so on
connect poorly to daily patient care. Therefore, the
question arises whether conclusions drawn from
such research are also valid in real-world applica-
tions. In short, RCTs opt for internal validity at the
expense of external validity. To offer a synthesis in
this discussion, Leichsenring (2004) has argued that
the RCT and the quasi-experimental study do not
differ in principle concerning their external and
internal validity, given their own specific context
(the laboratory and the field, respectively).
In this article, we focus on the consequences of
randomization for the feasibility and conclusive
power of RCTs in LTP investigations because we
are convinced that this is even more of a problem
for long-term treatments than for short-term treat-
ments.
Acceptability, Feasibility, and Conclusive
Power of RCTs in LTP Research
Based on chance, RCTs compare a treatment to be
examined (the experimental one, in this case LTP)
with a control condition. The following seven alter-
natives qualify as control conditions: no treatment,
wait list, placebo treatment, treatment as usual
(TAU), the experimental LTP in a low dose, another
LTP with an assumed but unproven efficacy, and
another LTP with established efficacy.
No treatment, wait list, placebo treatment. RCTs
comprising one of the first three control conditions
(no treatment, wait list, or placebo) provide the








































































strongest proof of efficacy. As far as LTP is con-
cerned, however, they merely are theoretical options,
because few well-informed patients will participate
in a study lasting at least 1 year and offering a 50%
chance on no treatment, wait list, or treatment only
resembling psychotherapy. Should anyone accept the
chance on such control conditions and indeed be
allocated to one, it can be safely assumed that he or
she will seek treatment elsewhere in the course of the
year. If, by chance, that patient would be compliant
with the control condition, he or she is most
certainly not representative of the study population.
In short, these RCTs are almost unfeasible when
they are conclusive, and they are inconclusive when
they are feasible. It is a small wonder they are not
found in the literature.
TAU. RCTs can compare LTP with TAU. (See,
e.g., Bateman & Fonagy, 1999; Linehan, Armstrong,
Suarez, Allmon, & Heard, 1991; Linehan, Dimeff,
Reynolds, Comtois, Welch, & Kivlahan, 2002; Line-
han, Schmidt, Dimeff, Craft, Kanter, & Comtois,
1999; Verheul, van den Bosch, Koeter, de Ridder,
Stijnen, & van der Brink, 2003; all studied patients
with borderline personality disorder [BPD]). This
design is feasible because there is an acceptable TAU
for BPD patients, namely treatment at a psychiatric
outpatient clinic. Bateman and Fonagy (2000)
clearly favor this study type: ‘‘Waiting-list controls
cannot be used to control for change over long
periods of time, and so are of limited use. The most
stringent control group without ethical problems is
TAU which should be used in the future, even
though heterogeneity of interventions and differen-
tial responsiveness within groups may obscure re-
sults.’’ To our knowledge, no RCTs compare LTP
and TAU in non-BPD-patients, not because there is
no LTP for these patients but because there is no
acceptable TAU for well-informed patients. Without
exaggeration, it may be said that TAU mostly
consists of minimal therapy, hardly rising above the
first three options mentioned previously. It has been
said that TAU comes down to cheap, low-frequency
treatment provided by minimally trained paraprofes-
sionals with an overwhelming caseload struggling to
get by (Scheel, 2000). What patient would be
prepared to chance such control condition in a
long-term study? Borderline patients do; what else
could they do? In short, regarding LTP, the feasi-
bility of RCTs comprising TAU as control condition
is clearly limited.
Experimental LTP in a low dose. In this design, LTP
in a dose considered normal is compared with LTP
in a lower dose. In pharmacological studies, this
generally means a dose considered ineffective, in fact
a placebo in disguise, unless several doses are tested
in search of a doseresponse curve. In the context of
psychotherapy, the term dose refers to session
frequency. This control condition is possibly more
acceptable to patients, but a problem arises with the
possible outcome of this research type. Only an
apparent difference in effectiveness is conclusive;
finding no difference may as well signify that the two
treatments are efficacious as that they are both
inactive. To correctly interpret a negative result
(finding no difference between the two dosages), it
is necessary to use the natural course of the disorder
(the course of the disorder untreated) as a reference.
If the natural course is known, however, cohort
studies would suffice.
There is yet another drawback to comparing two
psychotherapy doses. A large dose difference (e.g.,
two sessions weekly vs. one every 2 weeks) increases
the probability of finding a difference in effect, thus
enhancing the conclusive power of the study. How-
ever, it decreases the acceptability of the control
condition to patients, thus reducing the feasibility of
the study. In contrast, a small dose difference (e.g.,
four vs. three sessions weekly) increases the accept-
ability, and thus the feasibility, of the study but
decreases the probability of finding a difference in
effect and thus the conclusive power of the study.
This RCT type is either conclusive but hardly
feasible or highly feasible but poorly conclusive. It
seems that the conclusive power and the feasibility of
RCTs are two enemies convicted to one another.
Another LTP with an assumed but unproven efficacy.
This study type compares two LTPs, the efficacy of
which is assumed although it has not been proven in
conclusive RCTs. An RCT comparing schema
therapy (Young, Klosko, & Weishaar, 2003) with
transference-focused psychotherapy (Kernberg,
Clarkin, & Yeomans, 2002) is an example. Which
of the two treatments represents the control condi-
tion depends on the researchers’ perspective. The
acceptability and the feasibility of this design are fair.
However, here too only finding a difference in effect
is conclusive (unless the natural course of the
disorder is known, which would render the RCT
superfluous). When researchers sincerely believe that
two treatment methods are roughly equivalent, the
probability of finding a difference is low. In short, in
most cases, this study design is fairly feasible but
poorly conclusive.
Another LTP with established efficacy. This design
compares LTP with another LTP with undisputed
efficacy. Dialectic behavior therapy (Linehan et al.,
1991, 1999, 2002; Verheul et al., 2003) and menta-
lization-based therapy (Bateman & Fonagy, 1999) in








































































the treatment of BPD patients qualify as such
control conditions. Acceptability and thus feasibility
of this RCT type are passable. However, two new
problems arise. The first involves the conclusive
power of this research type. Finding a difference in
favor of the experimental treatment would naturally
be instructive, but the chances are slim. This study
design is primarily applied when the aim is to find no
difference in order to conclude that the new method
is equal in efficacy to the established one (the ‘‘me
too’’ method). No difference may be found, but that
does not necessarily mean that the new method
differs as clearly as the established one from a control
condition that implies no treatment, a wait list, or a
placebo. The second and most prominent problem is
that there are no LTPs with RCT-proven efficacy for
non-BPD patients.
Cohort Studies and LTP
Internal and External Validity of Cohort
Studies
When RCTs are not feasible, what is the highest
level of empirical evidence? According to the Centre
for Evidence-Based Medicine (2001) hierarchy of
evidence, the answer must be cohort studies. Com-
pared with RCTs, cohort studies have a lower
internal validity. However, the external validity is
higher because they present less selection bias. In
addition, in most designs cohort studies investigate
treatment methods conforming to norms that hold in
daily practice, whereas RCTs do not.
Acceptability, Feasibility, and Conclusive
Power of Cohort Studies in LTP
In cohort studies, only the acceptability of the
treatment condition counts, not that of a control
condition as well. Therefore, the feasibility of cohort
studies is, especially in LTP, better than that of RCTs.
The conclusive power of cohort studies is still a
matter of debate. Many believe that cohort studies
tend to overestimate the effects of treatments,
because there is no correction for potential con-
founders, meaning that the comparability of the
treated and the untreated groups may be doubted
(Sacks, Chalmers, & Schmidt, 1982; Kunz & Ox-
man, 1998). Theoretically, this is certainly possible,
but whether overestimation does actually occur in
practice remains to be seen. An exhaustive and
impressive study, published in the New England
Journal of Medicine (Concato, Shah, & Horwitz,
2000), compared the results of RCTs with those of
cohort studies using the same interventions in five
different somatic disorders. Review of 72 meta-
analyses of RCTs, 24 meta-analyses of cohort
studies or casecontrol studies, and 6 meta-analyses
involving both designs demonstrated that the results
of the observational studies remarkably resembled
those of the RCTs. Concato et al. concluded that
‘‘the popular belief that only randomized, controlled
trials produce trust-worthy results and that all
observational studies are misleading does a disser-
vice to patient care, clinical investigation, and the
education of health care professionals.’’ It may be
clear that these findings are important in light of the
discussion on research into the effectiveness of LTP.
The conclusive power of cohort studies depends
on the methodological quality of studies themselves
and on the knowledge of the natural course of the
disorders studied.
Methodological quality of cohort studies. The actual
structure of cohort studies is often looser than that of
RCTs, resulting in the general misconception that
cohort studies are of lower quality than RCTs.
Except for randomization, the assessment criteria
for the methodological quality of intervention cohort
studies do not differ from those for RCTs. Both
research types can be of superior or inferior quality.
It is in this light that Leichsenring (2004) has
proposed a hierarchy of evidence for both RCTs
and quasi-experimental studies based on criteria that
do not represent a sine qua non condition for high-
level research. As a rule, they are not categorical
(yesno) but dimensional (studies meet them from a
slight to considerable extent) and include, but are
not limited to, prospective study design; a control
group, preferably by means of extensive matching;
specific, homogeneous, and representative study
groups; clearly defined, specific, and representative
treatments of adequate duration; follow-ups of
adequate duration; pre-, post-, and follow-up assess-
ments; reliable and valid instruments applied by
independent assessors; adequate statistical proces-
sing; acceptable dropout percentage during treat-
ment and follow-up; intention-to-treat and per
protocol approaches and dropout accountability.
Cohort studies are prospective or retrospective.
They can, but do not necessarily have to, include a
control group (of course, not randomized; Kazin,
1998; Shadish et al., 2002). Single-group cohort
designs monitor one study group. There is no
control group. Pre- and postmeasuring makes each
patient functioning as his or her own control.
Multigroup cohort designs monitor at least two
groups: One is exposed to the intervention (e.g.,
psychoanalysis) and the other is often an otherwise
treated control group (e.g., psychoanalytic psy-
chotherapy). If the groups are matched on relevant
variables, the results of both groups can be cau-
tiously compared. Matching involves variables (e.g.,








































































demographical and diagnostic characteristics),
which might contribute to the differences in effect.
Matching is not an all-or-none phenomenon. The
smaller the number of variables included in the
matching, the less the control group deserves its
name. Epidemiological data regarding the general
population may also serve as a control for the results
of cohort studies. Untreated groups in epidemiolo-
gical research (which reflect the natural course of a
condition) can be compared with treated cohorts.
Again, the more the persons from epidemiological
studies are matched to the cohort, the stronger is the
evidence.
Natural courses of the disorders treated with LTP.
Knowledge of the natural course of the disorder
enhances the conclusive power of cohort studies
considerably. The natural course is the spontaneous
remission rate of the disorder under study among
untreated patients. Although the efficacy of the
surgical removal of an inflamed appendix has not
been investigated in any RCT, nobody considers this
a problem. People are convinced they know suffi-
ciently well the natural course of appendicitis to
consider RCTs in this case superfluous and on
ethical grounds unacceptable.
Knowledge of the natural course of disorders can
be based on clinical experience (as is the case with
appendicitis), but results from epidemiological re-
search are preferable. In practice, it proves difficult
to determine the real (because untreated) natural
course of disorders treated with LTP. A number of
studies may serve as an example. Spijker et al.
(2000) studied the course of major depression
(MDD) in The Netherlands. It appeared that 50%
of all new cases recover within the first 3 months.
After that period the probability of remission
diminishes and becomes nil after 12 months. After
2 years 26% are still not remitted. Two studies
suggest they provide relevant information on the
natural course of BPD. Perry et al. (1999) con-
cluded, based on a survey of five studies, that 2 and
10 years after treatment termination, respectively,
19% and 48% of BPD patients have recovered, for a
remission rate of 3.6% per year between the 2nd and
10th years. Zanarini, Frankenburg, Hennen, and
Silk (2003) concluded, based on one study (N/
290), that 2 and 6 years after treatment termination,
respectively, 35% and 66% have recovered, for a
remission rate of 7.7% per year between the 2nd and
6th years. Based on these results, the remission
percentage of BPD could roughly be estimated at
6% a year. In this context, however, the term
recovered only means that the patient no longer
meets the Diagnostic and Statistical Manual of Mental
Disorders criteria for BPD. Unfortunately, the three
studies mentioned previously relate to the course,
not to the natural course, of the disorder. Perry et al.
and Zanarini et al. relate to the course of BPS after
termination of intensive treatment. In addition, most
patients in these three studies had sought and
received help during the follow-up period. It may
be assumed that the natural course of disorder is
even less favorable than presented (unless one
assumes that treatment is to no avail or even worsens
the outcome).
In short, knowledge of the natural course of
disorders is scarce, but epidemiological research of
untreated disorders is necessary to enhance the
conclusive power of any long-term treatment study.
Discussion
This article discusses two premises that are more or
less explicitly taken for granted in research regarding
the efficacy of LTP: (a) Conclusive RCTs are
feasible in LTP research and (b) RCTs are superior
to cohort studies in all important methodological
aspects.
Feasibility of Conclusive RCTs
In RCTs randomization warrants unsurpassed inter-
nal validity. However, the treatment condition as
well as the control condition must be acceptable.
Otherwise, the study is impracticable. Acceptability
of the control condition is often difficult enough in
STP studies. In LTP studies the problem, as a rule,
is almost insurmountable. The consequences are
considerable. First, the more limited the acceptabil-
ity of the control condition, the smaller is the
percentage of the study population that will agree
to the study conditions and the larger the selection
bias. However, our main argument involves another
aspect. Conclusive control conditions (no treatment,
wait list, placebo) are, as far as LTP is concerned,
unacceptable. More acceptable control conditions
(other treatment modalities), if they exist at all, are
less conclusive. All too often, researchers have to
choose between either hardly feasible designs with
high conclusive powers or passably feasible designs
with low conclusive power.
Thus far, the literature has paid insufficient
attention to the limited acceptability of control
conditions to patients and the subsequent problems
for RCTs. There is extensive literature on patient
dropout after treatment has started. There is also a
good deal of literature on patients’ refusal to start the
treatment to which they have been randomized (the
difference between intention-to-treat design and per
protocol design). There are, however, almost no
publications regarding patients’ refusal to participate








































































in a study because they do not accept the possibility
of being allotted to the control condition.
The problems outlined previously are limitations
not of the treatment method but of the research
method. The factors determining the limitations
relate to the duration, not type, of treatment. They
are by no means specific to LTP research but apply
in general to research of long-term treatments,
whether they are of a somatic or a psychological
nature.
Methodological Qualities of RCTs and Cohort
Studies
General quality criteria apply to intervention re-
search, some of which have been mentioned before.
Neither RCTs nor cohort studies can meet all
criteria because of, among other factors, randomiza-
tion (at the expense of external validity) and lack of
randomization (at the expense of internal validity).
Apart from these inherent limitations, RCTs and
cohort studies, in actual practice, vary in quality and
are both able to meet all other criteria for interven-
tion studies. We discussed two specific problems of
cohort studies.
The inclusion of a control group enhances the
credibility of cohort studies. The greater the number
of variables included in the matching, the more
decisive power the study has. However, the relevance
of matching must not be overestimated. After all, it is
never certain whether all relevant factors have been
taken into account in the matching.
Furthermore, the conclusive power of cohort
research is codetermined by the control knowledge
of the natural (i.e., untreated) course of the disorders
studied. Progress in epidemiological research is
badly needed, but there are unresolved, possibly
insoluble, problems. People who suffer understand-
ably seek help, and in our society they often get it.
Consequently, the natural, untreated course of many
disorders suitable for LTP treatment is hardly
known. There is still another problem if data
regarding the general population are gathered. This
group differs from the group treated in a cohort
study in one essential aspect (possibly an important
confounder): help-seeking behavior.
Where scientific arguments make default, clinical
experience retains its rights. In other words, for lack
of epidemiological knowledge regarding the natural
course of the disorders suitable for LTP treatment,
one has to accept the guidance of clinical experience.
LTP seems mostly indicated for long-existing pro-
blems. Leichsenring and Leibing (2003) conclude
that ‘‘several studies reported more improvement in
personality disorders after longer treatment dura-
tions.’’ Kopta, Howard, Lowry, and Beutler (1994)
also found that improvements in character problems
take longer than symptom changes. In the context of
stepped care, LTP is also indicated in case STP
appears insufficiently effective. The latter is by no
means exceptional; on the contrary, there are strong
indications that the effects of short-term therapies
are short lived. In an extensive review, Gloaguen,
Cottraux, Cucherat, and Blackburn (1998) showed
that relapse rates after short-term treatment for
depression with psychotherapy and pharmacother-
apy varied, on average, from 30% to 60%. Two time-
honored adages apply here: (a) The longer the
duration of disorders and the more frequently they
have been treated to no avail, the less likely it is that
they will remit spontaneously. Time rarely heals old
and ineffectively treated wounds.
Conclusion
RCTs constitute an inadequate research methodol-
ogy for studying LTP effectiveness, except with
BPD. RCTs represent not the highest but rather an
irrelevant level of empirical evidence. Where RCTs
are an impracticable and, therefore, inadequate
research method, cohort studies provide the best
available evidence.
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